With respect to XPD Lys751Gln polymorphism, a meta-analysis by Zhang and Mou15 did not find any evidence of significant association between XPD Lys751Gln polymorphism and HCC risk in the overall populations and subgroup analysis. Here, ERCC2 is linked to hepatocellular carcinoma.